Country: Austria
Language: English
Source: HMA (Heads of Medicines Agencies)
febantel 15 mg/ml, pyrantel embonate 14.4 mg/ml
Bayer plc Animal Health
QP52AF02
Oral suspension
pyrantel
Dogs
2010-11-19
Revised: July 2013 AN. 00859/2012 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MEMBER STATE PROPOSED NAME AT Drontal Junior DE Welpan für Welpen und junge Hunde EE Drontal Puppy FI Welpan vet FR Dronstop Chiot ES Drontal suspensión oral para cachorros y perros jóvenes IE Drontal Oral Suspension for Puppies IS Welpan vet LT Drontal Puppy LV Drontal Puppy NO Welpan vet UK Drontal Oral Suspension for Puppies Febantel 15 mg/ml / Pyrantel 5 mg/ml Oral Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION EACH ML CONTAINS ACTIVE SUBSTANCES: Febantel 15.00mg Pyrantel 5.00mg (as pyrantel embonate 14.40mg) EXCIPIENTS: Sodium benzoate (E211) 2.05mg Sodium propionate (E281) 2.05mg Ponceau 4R (E124) 0.25mg For a full list of excipients, see section 6.1. Revised: July 2013 AN. 00859/2012 Page 2 of 6 3. PHARMACEUTICAL FORM Oral suspension Pale red suspension 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs (puppies and young dogs up to one year of age) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of roundworm infections in puppies and young dogs up to one year of age caused by: Ascarids: Toxocara canis Toxascaris leonina Hookworms: Ancylostoma caninum Uncinaria stenocephala Whipworm: Trichuris vulpis 4.3 CONTRAINDICATIONS Do not use simultaneously with compounds containing piperazine. See sections 4.7 and 4.8. 4.4 SPECIAL Read the complete document